Additive Orthopaedics has sold its product lines to Paragon 28, Inc. England Securities served as Additive’s exclusive financial advisor. This represents England's second M&A transaction in foot and ankle orthopedics this year and serves to further establish the firm as the leading investment bank for this sector.

Additive Orthopaedics, based in Little Silver, NJ, leverages state-of-the-art 3D metal printing technology to design, manufacture, and market patient-specific and off-the-shelf implants specializing in complex reconstructions, implant revisions, and limb salvage procedures.

This transaction included their 3D-printed Patient Specific Talus Spacer, approved for use by the U.S. Food and Drug Administration this February, and Additive's internally developed, proprietary pre-operative surgical planning application.

"Additive had significant buyer interest, so the Board decided to hire England & Company because of their demonstrated expertise and track record in foot & ankle orthopedics," said Tony Dimun, a Director of Additive Orthopaedics. "England performed an excellent job in creating strategic alternatives."

Paragon 28 exclusively serves the foot-and-ankle surgical community and is dedicated to enhancing patient outcomes by advancing the science and research behind innovative technologies. The addition of Additive Orthopaedics' assets bolsters Paragon 28's Precision Ankle Solutions product offerings. With this comprehensive portfolio, Paragon 28 provides its customers innovative ankle solutions for trauma, arthritis, and limb salvage.